Craig Berman
Hoofd Techniek/Wetenschap/O&O bij SUTRO BIOPHARMA, INC.
Oorsprong van het eerstegraads netwerk van Craig Berman
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses
336
| College/University | Other Consumer Services | 336 |
| Public Company | Pharmaceuticals: Major | 30 | |
University of Colorado Health Sciences Center
10
| College/University | Other Consumer Services | 10 |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., QED Therapeutics, Inc. is a biotechnology company based in Palo Alto, CA. The company focuses on precision medicine for FGFR-driven diseases and is committed to finding solutions to FGFR-driven cancers and diseases to give patients more possibilities. QED Therapeutics' lead investigational candidate is infigratinib, an orally administered, FGFR1-3 selective tyrosine kinase inhibitor that has shown activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and advanced urothelial carcinoma with FGFR3 genomic alterations. In 2020, QED submitted a new drug application (NDA) with the Food and Drug Administration for second- and later-line cholangiocarcinoma. Michael Henderson has been the CEO of the company since 2017.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Craig Berman via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| CISCO SYSTEMS, INC. | Telecommunications Equipment | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Investor Relations Contact Corporate Officer/Principal Sales & Marketing | |
| MICROSOFT CORPORATION | Packaged Software | Corporate Officer/Principal | |
| PEPSICO, INC. | Food: Specialty/Candy | Corporate Officer/Principal Director/Board Member | |
| QUALCOMM, INC. | Semiconductors | Corporate Officer/Principal | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
CIBC Private Wealth Advisors, Inc.
 CIBC Private Wealth Advisors, Inc. Investment ManagersFinance CIBC Private Wealth Advisors, Inc. (CPWA) is a SEC-registered investment advisor headquartered in Chicago, Illinois. The firm was founded in 1932 and formerly known as AT Investment Advisers, Inc. They are a subsidiary of CIBC Private Wealth Group LLC, ultimately held by Canadian Imperial Bank of Commerce (NYSE, TSE: CM) in Canada. CPWA provides investment advisory and wealth advisory services to individuals, trusts, estates, families, charitable organizations, employee benefit and contribution plans, corporations, state or municipal government entities, pension and profit-sharing plans, and other investment advisers. The firm also participates in wrap fee programs offered by third party sponsors. | Investment Managers | Portfolio Manager-Equities Analyst-Equity Portfolio Manager-Equities | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Nortel Networks, Inc.
 Nortel Networks, Inc. Major TelecommunicationsCommunications Nortel Networks, Inc. provides digital network solutions and services. It offers end-to-end broadband, voice over Internet Protocol, multimedia services and applications, and wireless broadband technology solutions. The company is headquartered in Nashville, TN. | Major Telecommunications | Corporate Officer/Principal | |
| University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Founder | |
PellePharm, Inc.
 PellePharm, Inc. BiotechnologyHealth Technology PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. The firm also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Michael Henderson, Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Founder | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| ZURICH INSURANCE GROUP LTD | Multi-Line Insurance | Director/Board Member Corporate Officer/Principal | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Trading-Equity Economist | |
| University of Missouri | College/University | Undergraduate Degree Doctorate Degree | |
| Xavier University | College/University | Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree | |
| Indiana University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree | |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Origin Biosciences, Inc. is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The company is based in Palo Alto, CA. The company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector. Michael Henderson has been the CEO of the company since 2018. | Pharmaceuticals: Major | President Corporate Officer/Principal Chief Executive Officer | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Corporate Officer/Principal Founder Corporate Officer/Principal | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| Adrenas Therapeutics, Inc. | Treasurer Director/Board Member | ||
| DIMENSION THERAPEUTICS INC | Biotechnology | Treasurer Director/Board Member | |
| The University of Michigan Law School | College/University | Graduate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Biotechnology | Founder Corporate Officer/Principal | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
Program Planning Professionals, Inc.
 Program Planning Professionals, Inc. Miscellaneous Commercial ServicesCommercial Services Program Planning Professionals, Inc. offers portfolio, program and project management solutions. Its services include change management, portfolio management, program leadership and project delivery. The company was founded by Adrian Balfour, Paul Driver and Leonora Balfour in March 1994 and is headquartered in Ann Arbor, MI. | Miscellaneous Commercial Services | Director/Board Member | |
InfrAegis, Inc.
 InfrAegis, Inc. Miscellaneous Commercial ServicesCommercial Services InfrAegis, Inc. provides security technology and media distribution services. Its products include radioactive isotope detection, computer-aided trace detection, and incident video synchronization systems. The company was founded in April, 2003 and is headquartered in Washington, DC | Miscellaneous Commercial Services | Chief Executive Officer | |
| AT&T INC. | Wireless Telecommunications | Corporate Officer/Principal | |
| Kalobios Pharmaceuticals, Inc. | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 48 |
| Zwitserland | 2 |
| Duitsland | 2 |
Sectoraal
| Consumer Services | 17 |
| Health Technology | 12 |
| Finance | 8 |
| Commercial Services | 6 |
| Electronic Technology | 5 |
Operationeel
| Director/Board Member | 275 |
| Corporate Officer/Principal | 224 |
| Undergraduate Degree | 95 |
| Independent Dir/Board Member | 68 |
| Chairman | 61 |
Sterkste connecties
| Insiders | |
|---|---|
| John Freund | 37 |
| William Glastris | 32 |
| Fred Kindle | 28 |
| Steven Lefkowitz | 26 |
| Gary A. Mecklenburg | 26 |
| Michael Bender | 21 |
| Christopher Joseph Clower | 21 |
| Neil Kumar | 18 |
| David M. Garrity | 18 |
| Rob Brown | 18 |
| Michael Dybbs | 17 |
| Daniel Petree | 17 |
| Shalini Sharp | 17 |
| Richard M. Armbrust | 16 |
| Richard Afable | 15 |
- Beurs
- Insiders
- Craig Berman
- Bedrijfsconnecties
